Abstract:Background. Aneurysmal subarachnoid hemorrhage (aSAH) is an acute cerebrovascular illness with a pronounced rate of disability and fatality. Assessing the risk of rupture in unruptured intracranial aneurysms (UIAs) can guide early clinical intervention to avoid subarachnoid hemorrhage (SAH). Current methods to assess the occurrence of aSAH at the molecular level are inadequate. Numerous studies have shown that immunity and inflammation are the initiating factors of UIAs rupture, which provides a potential theoretical support for constructing a risk model for aSAH occurrence based on immune-related genes. Methods. GSE36791 containing 61 samples was used as the training set, and GSE73378 containing 226 samples was used as the validation set, and the above data sets were obtained from the Gene Expression Omnibus database. All samples were gene expression profiling from peripheral blood cells. Using R software to identify differential genes and key gene modules and explore the underlying biological processes of differential genes. Immune-related analyses were based on ssGSEA and CIBERSORT algorithms. Using Cox regression to fit the risk model for aSAH occurrence with 3 randomly selected immune-related genes, and validating the model in the test set. Result. A total of 22 hub genes were obtained by weighted gene co-expression network analysis and gene differential expression analysis. Functional enrichment analysis showed that hub genes were mainly enriched in immune and inflammation-related pathways. The results showed that neutrophils and monocytes made up the largest proportion of the samples. CD6, SLP and SLC2A11 were randomly selected to construct risk model for aSAH occurrence. Our analysis resulted in an AUC value of 0.859 for the training set and 0.627 for the validation set, indicating that the model has some accuracy and potential clinical application. Conclusion. We identified 22 key genes associated with immunity and randomly selected 3 genes to construct and validate a risk model for the development of SAH due to aneurysm rupture. We determined the likelihood of intracranial aneurysm rupture based on the model score. It is possible to quickly and conveniently guide whether early intervention is needed for unruptured aneurysms at the molecular level to prevent the formation of SAH and related complications. In addition, pivotal gene-mediated inflammation provides a new perspective for future studies on the mechanisms of aSAH initiation and subsequent neurological deterioration.

Identifying Critical Genes Associated with Aneurysmal Subarachnoid Hemorrhage by Weighted Gene Co-Expression Network Analysis

Identification of the Key Immune-Related Genes in Aneurysmal Subarachnoid Hemorrhage

Analysis of Peripheral Blood Cells' Transcriptome in Patients with Subarachnoid Hemorrhage from Ruptured Aneurysm Reveals Potential Biomarkers.

Specific signature biomarkers highlight the potential mechanisms of circulating neutrophils in aneurysmal subarachnoid hemorrhage

Bioinformatics analysis reveals potential biomarkers associated with the occurrence of intracranial aneurysms

Identifying and validating key genes mediating intracranial aneurysm rupture using weighted correlation network analysis and exploration of personalized treatment

Identification and validation of key genes mediating intracranial aneurysm rupture by weighted correlation network analysis

The Role of the Blood Neutrophil-to-Lymphocyte Ratio in Aneurysmal Subarachnoid Hemorrhage

Immune-related Genes Construct and Validate a Risk Model for Aneurysm Rupture Leading to Subarachnoid Hemorrhage

Comparative Analysis of Aneurysm Subtypes Associated Genes Based on Protein–protein Interaction Network

The Identification and Validation of Hub Genes Associated with Acute Myocardial Infarction Using Weighted Gene Co-Expression Network Analysis.

Gene expression profiles and related immune-inflammatory factors in the cerebral arteries in mouse models of subarachnoid haemorrhage

Expression Profile Analysis of Differentially Expressed Genes in Ruptured Intracranial Aneurysms: in Search of Biomarkers.

Identification of Hub Genes Associated with the Pathogenesis of Intracranial Aneurysm via Integrated Bioinformatics Analysis

Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms

Identification of Key Genes as Early Warning Signals of Acute Myocardial Infarction Based on Weighted Gene Correlation Network Analysis and Dynamic Network Biomarker Algorithm

Identification of Potential Biomarkers Associated with Acute Myocardial Infarction by Weighted Gene Coexpression Network Analysis

Screening of Critical Genes and MicroRNAs in Blood Samples of Patients with Ruptured Intracranial Aneurysms by Bioinformatic Analysis of Gene Expression Data.

Identifying novel risk genes in intracranial aneurysm by integrating human proteomes and genetics

Comprehensive analysis of immune cell infiltration and role of MSR1 expression in aneurysmal subarachnoid haemorrhage

Weighted Gene Coexpression Network Analysis Identifies Crucial Genes Involved in Coronary Atherosclerotic Heart Disease